BPC Factory direct sales Tirzepatide Weight loss Raw material Bpc High Quality 99% Purity
15990-43-9
Pharmaceutical Grade
99%
shenzhen
ZQ
10mg*10vials
2026-07-16 ~ 2026-09-01
Semaglutide
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceN-Benzylniacin(BPC) is a colorless to yellowish transparent liquid.Basic Info
-
Product Name:
N-Benzylniacin
Other Name:1-Benzyl-3-carboxypyridinium hydroxide inner salt;1-benzyl pyridinium-3-carboxylate;N-BENZYLNIACIN;N-BENZYLNICOTINAMIDE;N-Benzyl nicotinate betaine;N-Benzylpyridinium-3-carboxylate;pyridinium,3-carboxy-1-(phenylmethyl)-,hydroxide,innersalt;Pyridinium,3-carboxy-1-(phenylmethyl)-,innersalt
CAS No.:15990-43-9
Molecular Formula:C13H11NO2
InChIKeys:AVWFAACIXBQMBF-UHFFFAOYSA-N
Molecular Weight:213.24
Exact Mass:213.078979
EC Number:240-129-1
TSCA:TSCA listed
DSSTox ID:DTXSID0065989
Color/Form:light yellow
HScode:2933399090
Categories:
Characteristics-
PSA:
44
XLogP3:-2.74
Appearance:light yellow paste
Density:1.09
Refractive Index:1.625
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) none
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Semaglutide
-
Location:
hangzhou
-
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment
-
Average lead Time:
2
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2025
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product